Hepatitis B virus in drug users in France: prevalence and vaccination history, ANRS-Coquelicot Survey 2011-2013

C Brouard, J Pillonel, P Sogni, A Chollet, J V Lazarus, X Pascal, F Barin, M Jauffret-Roustide, ANRS Coquelicot Survey Group

    9 Citationer (Scopus)

    Abstract

    People who use drugs (PWUD) are a key population for hepatitis B virus (HBV) vaccination and screening. We aimed to estimate the seroprevalence of HBs antigen (HBsAg) and self-reported HBV vaccination history in French PWUD attending harm reduction centres using data from the ANRS-Coquelicot multicentre survey conducted in 2011-2013 in 1718 PWUD. Self-fingerprick blood samples were collected on dried blood spots to detect the presence of HBsAg. HBsAg seroprevalence was estimated at 1·4% [95% confidence interval (CI) 0·8-2·5]. It varied between PWUD born in high (7·6%, 95% CI 2·7-19·1), moderate (2·2%, 95% CI 0·8-5·7) and low (0·7%, 95% CI 0·3-1·5) endemic zones. Factors independently associated with HBsAg carriage were being born in a moderate or high endemic zone or reporting precarious housing. Self-reported HBV vaccination history varied from 47·4% in high endemic zones, to 59·3% and 62·6% for moderate and low endemic zones, respectively. Our results suggest that drug use plays a small and substantial role, respectively, in HBsAg carriage in PWUD born in high/moderate and low endemic zones.

    OriginalsprogEngelsk
    TidsskriftEpidemiology and Infection
    Vol/bind145
    Udgave nummer6
    Sider (fra-til)1259-1269
    ISSN0950-2688
    DOI
    StatusUdgivet - apr. 2017

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Hepatitis B virus in drug users in France: prevalence and vaccination history, ANRS-Coquelicot Survey 2011-2013'. Sammen danner de et unikt fingeraftryk.

    Citationsformater